Anal cancer: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 1: Line 1:
{{Editor Help}}
'''For patient information click [[{{PAGENAME}} (patient information)|here]]'''{{Editor Help}}


==Overview==
==Overview==

Revision as of 12:47, 31 July 2009

'For patient information click here'Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [3] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

WikiDoc Resources for Anal cancer

Articles

Most recent articles on Anal cancer

Most cited articles on Anal cancer

Review articles on Anal cancer

Articles on Anal cancer in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Anal cancer

Images of Anal cancer

Photos of Anal cancer

Podcasts & MP3s on Anal cancer

Videos on Anal cancer

Evidence Based Medicine

Cochrane Collaboration on Anal cancer

Bandolier on Anal cancer

TRIP on Anal cancer

Clinical Trials

Ongoing Trials on Anal cancer at Clinical Trials.gov

Trial results on Anal cancer

Clinical Trials on Anal cancer at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Anal cancer

NICE Guidance on Anal cancer

NHS PRODIGY Guidance

FDA on Anal cancer

CDC on Anal cancer

Books

Books on Anal cancer

News

Anal cancer in the news

Be alerted to news on Anal cancer

News trends on Anal cancer

Commentary

Blogs on Anal cancer

Definitions

Definitions of Anal cancer

Patient Resources / Community

Patient resources on Anal cancer

Discussion groups on Anal cancer

Patient Handouts on Anal cancer

Directions to Hospitals Treating Anal cancer

Risk calculators and risk factors for Anal cancer

Healthcare Provider Resources

Symptoms of Anal cancer

Causes & Risk Factors for Anal cancer

Diagnostic studies for Anal cancer

Treatment of Anal cancer

Continuing Medical Education (CME)

CME Programs on Anal cancer

International

Anal cancer en Espanol

Anal cancer en Francais

Business

Anal cancer in the Marketplace

Patents on Anal cancer

Experimental / Informatics

List of terms related to Anal cancer

Anal cancer is a type of cancer which arises from the anus, the distal orifice of the gastrointestinal tract. It is a distinct entity from the more common colorectal cancer. The etiology, risk factors, clinical progression, staging, and treatment are all different. Anal cancer is typically a squamous cell carcinoma that arises near the squamocolumnar junction.

Epidemiology

Incidence[1]

  • In women and men who do not engage in anal intercourse with other men - 0.9/100,000
  • In HIV negative men who engage in anal intercourse with other men - 35/100,000
  • In HIV positive men who engage in anal intercourse with other men - (estimated) 60-70/100,000

Anal cancer is uncommon and accounts for only 4% of all cancers of the lower alimentary tract. There are estimated to be 4,650 new cases and 690 deaths from anal cancer in the United States in 2007.[2] Because it is rare and because it occurs in a body part that is rarely discussed, most people are unaware of its existence.

Risk factors

  • Human papillomavirus (HPV) infection: An examination of squamous cell carcinoma tumor tissues from patients in Denmark and Sweden showed a high proportion of anal cancers to be positive for the types of HPV that are also associated with high risk of cervical cancer (90% of the tumors from women, 100% of the tumors from homosexual men, and 58% of tumors from heterosexual men).[3] In another study done, high-risk types of HPV, notably HPV-16, were detected in 84 percent of anal cancer specimens examined.[4]
  • Sexual activity: Having multiple sex partners or having anal sex, due to the increased risk of exposure to the HPV virus.[5]
  • Smoking: Current smokers are several times more likely to develop anal cancer compared with nonsmokers.[5]

Prevention

Since many, if not most, anal cancers derive from Human Papilloma Virus infections, and since the HPV vaccine prevents infection by several strains of the virus, scientists surmise that HPV vaccination will prevent anal cancer. [6]

Screening

Anal pap smears similar to those used in cervical cancer screening have been studied experimentally for early detection of anal cancer in high-risk individuals.[7][8]

Treatment

Localized disease

Anal cancer is most effectively treated with surgery, and in early stage disease (i.e., localized cancer of the anus without metastasis to the inguinal lymph nodes), surgery is often curative. The difficulty with surgery has been the necessity of removing the anal sphincter, with concomitant fecal incontinence. For this reason, many patients with anal cancer have required permanent colostomies.

In more recent years, physicians have employed a combination strategy including chemotherapy and radiation treatments to reduce the necessity of debilitating surgery. This "combined modality" approach has led to the increased preservation of an intact anal sphincter, and therefore improved quality of life after definitive treatment. Survival and cure rates are excellent, and many patients are left with a functional sphincter. Some patients have fecal incontinence after combined chemotherapy and radiation. Biopsies to document disease regression after chemotherapy and radiation were commonly advised, but are not as frequent any longer. Current chemotherapy active in anal cancer includes cisplatin and 5-FU; mitomycin has also been used, but is associated with increased toxicity.

Metastatic or recurrent disease

Up to 10% of patients treated for anal cancer will develop distant metastatic disease. Metastatic or recurrent anal cancer is difficult to treat, and usually requires chemotherapy. Radiation is also employed to palliate specific locations of disease that may be causing symptoms. Chemotherapy commonly used is similar to other squamous cell epithelial neoplasms, such as platinum analogues, anthracyclines such as doxorubicin, and antimetabolites such as 5-FU and capecitabine.

Prognosis

See also

References

  1. Anal Carcinoma [1]
  2. National Cancer Institute: Anal Cancer [2]
  3. Danish Medical Bulletin. 2002 Aug;49(3):194-209
  4. New England Journal of Medicine. 1997 Nov 6;337(19):1350-8
  5. 5.0 5.1 5.2 American Cancer Society. "What Are the Risk Factors for Anal Cancer?"
  6. Template:Http://www.iht.com/articles/2007/01/31/healthscience/sncancer.php
  7. Cichoki, Mark. "Anal Papilloma Screening" on About.com
  8. Chiao EY, Giordano TP, Palefsky JM, Tyring S, El Serag H (2006). "Screening HIV-infected individuals for anal cancer precursor lesions: a systematic review". Clin. Infect. Dis. 43 (2): 223–33. doi:10.1086/505219. PMID 16779751.

External links

Template:SIB Template:Tumors hu:Anális rák fi:Peräaukon syöpä


Template:WikiDoc Sources